AGILYSYS INC

AGYS

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 149,286Value: $17.7M

**Signal Note: Driehaus Initiates AGYS Position** Driehaus Capital's $17.7M entry into AgilySys (AGYS), a healthcare software/hospitality IT company, appears inconsistent with typical biotech-focused growth investing and lacks obvious near-term clinical catalysts. This position may reflect conviction in enterprise software consolidation thesis or operational improvements rather than pipeline-driven biotech dynamics, warranting clarification on investment thesis rationale.

More AGYS Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: